 |
January 29, 2008
Tranzyme Receives IND Clearance for
TZP-102
December 19, 2007
Tranzyme to Present at the 26th Annual
JPMorgan Healthcare Conference 
November 01, 2007
Tranzyme Pharma Closes New $20 Million Financing
TZP-101
selected by Thomson Pharma as one of the five most promising
Phase I drugs.
Click here to read more.

|
 |